JZJ(SH:605266) Xin Lang Cai Jing·2025-12-19 01:52Core Viewpoint - The stock price of Jianzhijia has experienced a decline of 10.24% year-to-date, with a recent slight recovery in the last five trading days, indicating potential volatility in the market performance of the company [2]. Group 1: Stock Performance - As of December 19, Jianzhijia's stock price decreased by 2.03%, trading at 19.76 yuan per share, with a total market capitalization of 30.54 billion yuan [1]. - The stock has shown a 2.60% increase over the last five trading days and a 0.51% increase over the last 20 days, while it has declined by 8.18% over the last 60 days [2]. Group 2: Financial Performance - For the period from January to September 2025, Jianzhijia reported a revenue of 6.549 billion yuan, reflecting a year-on-year decrease of 2.77%, and a net profit attributable to shareholders of 101 million yuan, down by 0.22% year-on-year [2]. - The company has distributed a total of 715 million yuan in dividends since its A-share listing, with 473 million yuan distributed over the past three years [3]. Group 3: Business Overview - Jianzhijia, established on September 27, 2004, and listed on December 1, 2020, operates in the health product retail sector, offering a range of products including pharmaceuticals, health foods, personal care items, and daily consumables [2]. - The revenue composition of Jianzhijia includes 72.60% from prescription and non-prescription drugs, with non-prescription drugs accounting for 39.64% and prescription drugs for 32.96% [2]. - The company is categorized under the pharmaceutical and biological industry, specifically in the offline pharmacy segment, and is associated with concepts such as retail pharmacies and family doctor services [2].